Journal Article Ahead of print
PubMed: 42264219 DOI: 10.1016/j.jaip.2026.06.001
Pembrolizumab-induced immediate hypersensitivity reactions.
J Allergy Clin Immunol Pract
Authors: Louise Guyot, Louise Collin, Pauline Sueur, Marion Verdaguer, Marie-Laure Uffredi, Marion Allouchery, Gonzague de Chabot, Céline Beauvillain, Circée Sperduto, Kevin Fouet, Fréderic Berard, Fabien Pelletier, Marina Babin, Hassan El Hanache, Martine Morisset
Affiliations
- Allergy Unit, Angers University Hospital, France.
- Allergy Unit, Angers University Hospital, France; Pulmonology and Allergy, Dijon University Hospital, France.
- Dermatology and Allergy Department, Saint Etienne University Hospital, France; Department of Dermatology, Jean-Minjoz Hospital, Besançon, France.
- Regional Allergy Center, Poitiers University Hospital, France.
- Department of Pulmonology, Laval Hospital, France.
- Department of Clinical Pharmacology, Poitiers University Hospital, Poitiers, France.
- Department of Pulmonology, Vannes Hospital, France.
- Laboratory of Immunology and Allergy, Angers University Hospital; Inserm U1232, team 4, CRCINA, Angers University.
- Department of Internal Medicine and Pulmonology Bar-le-Duc Hospital, France.
- Department of Pulmonology, St Louis Hospital, La Rochelle, France.
- Allergy and Clinical Immunology Department, Lyon-Sud University Hospital, France.
- Department of Dermatology, Jean-Minjoz Hospital, Besançon, France; Department of Dermatology, University of Franche-Comté, Inserm U1098, Besançon, France.
- Department of Pharmacology-Toxicology & Pharmacovigilance, Angers University Hospital.
- Allergy Unit, Department of Dermatology, Nantes University Hospital, CIC 1413, F-44000 Nantes, France.
MeSH
Hypersensitivity, Drug Hypersensitivity, Anaphylaxis, Basophil Degranulation Test, Hypersensitivity, Immediate